Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Archimedes Pharma

2005 FOUNDED
M&A STATUS
21-30 EMPLOYEES
M&A LATEST DEAL TYPE
4 FINANCING ROUNDS
2 INVESTMENTS
Description

Producer of pharmaceuticals in Europe. The company was created to form a pan-European specialty pharmaceutical company through a roll-up of European pharmaceutical businesses. It offers products that treat high grade glioma, cancer pain, alcohol misuse, thromboprophylaxis and moderate to severe pain.

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly PE-Backed
Primary Industry
Pharmaceuticals
Parent Company
Primary Office
  • 250 South Oak Way Green Park
  • Reading RG2 6UG
  • England, United Kingdom

+44 0118 000 0000

Archimedes Pharma Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Archimedes Pharma‘s full profile, request access.

Request full access to PitchBook

Archimedes Pharma Investments (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000000 000000 06-Nov-2006 0000000000 Other Healthcare Services 0000000 00 00000
West Pharmaceutical Services (Drug Delivery Business) 08-Feb-2005 Buyout/LBO Drug Delivery 0000000 00 00000
To view this company’s complete investment and acquisition history, request access »

Archimedes Pharma Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Archimedes Pharma‘s full profile, request access.

Request full access to PitchBook

Archimedes Pharma Executive Team (8)

Name Title Board
Seat
Contact
Info
Nicholas Lowcock Director
Charles Reinhart III Executive Vice President & Chief Financial Officer
Simon Turton Ph.D Director

5 Former Executives

You’re viewing 3 of 8 executives. Get the full list »